DoW Spinal Cord Injury, Clinical Trial Award

About the role

The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of spinal cord injury (SCI).

Distinctive Features

• This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
• Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners (e.g., SCI Lived-Experience Consultants, representatives of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.

Eligibility

• Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".
• Additional Information on Eligibility: See the full announcement for any additional eligibility requirements.

Funding Details

• Estimated Total Program Funding: $9,760,000
• Expected Number of Awards: 2
• Cost Sharing or Matching Requirement: No
• Current Closing Date for Applications: November 12, 2026

Grantor Contact Information

If you have difficulty accessing the full announcement electronically, please contact:

• eBRAP Help Desk
• Phone: 301-682-5507
• Email: help@eBRAP.org